Firefly Neuroscience, Inc. (AIFF)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Firefly Neuroscience, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Firefly Neuroscience, Inc. (AIFF) has returned 149.14% so far this year and -44.53% over the past 12 months. Over the last ten years, AIFF has returned -6.83% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Feb 23, 2011, AIFF's average daily return is +0.28%, while the average monthly return is +3.12%. At this rate, your investment would double in approximately 1.9 years.

Historically, 36% of months were positive and 64% were negative. The best month was Aug 2020 with a return of +261.1%, while the worst month was Mar 2023 at -62.4%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, AIFF closed higher 23% of trading days. The best single day was Feb 11, 2025 with a return of +171.0%, while the worst single day was Feb 14, 2025 at -41.7%.

Firefly Neuroscience, Inc. has an annualized alpha of 92.63%, beta of 0.50, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since February 24, 2011.

• This stock participated in 117.27% of S&P 500 Index downside but only 44.53% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.50 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AIFF ranks 35 for risk / return — below 35% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Firefly Neuroscience, Inc. (AIFF) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Firefly Neuroscience, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Firefly Neuroscience, Inc. was 99.64%, occurring on Feb 23, 2026. The portfolio has not yet recovered.

The current Firefly Neuroscience, Inc. drawdown is 98.76%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Firefly Neuroscience, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Firefly Neuroscience, Inc. is priced in the market compared to other companies in the Software - Application industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.